Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[68Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas.
Guberina N, Kessler L, Pöttgen C, Guberina M, Metzenmacher M, Herrmann K, Mucha M, Rischpler C, Indenkämpen F, Siveke JT, Treckmann J, Umutlu L, Kasper S, Fendler WP, Stuschke M. Guberina N, et al. Among authors: siveke jt. Sci Rep. 2022 Sep 28;12(1):16261. doi: 10.1038/s41598-022-20447-6. Sci Rep. 2022. PMID: 36171444 Free PMC article.
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.
Herrmann K, Erkan M, Dobritz M, Schuster T, Siveke JT, Beer AJ, Wester HJ, Schmid RM, Friess H, Schwaiger M, Kleeff J, Buck AK. Herrmann K, et al. Among authors: siveke jt. Eur J Nucl Med Mol Imaging. 2012 May;39(5):846-51. doi: 10.1007/s00259-012-2061-8. Epub 2012 Jan 26. Eur J Nucl Med Mol Imaging. 2012. PMID: 22278320
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.
Vogel A, Kasper S, Bitzer M, Block A, Sinn M, Schulze-Bergkamen H, Moehler M, Pfarr N, Endris V, Goeppert B, Merx K, Schnoy E, Siveke JT, Michl P, Waldschmidt D, Kuhlmann J, Geissler M, Kahl C, Evenkamp R, Schmidt T, Kuhlmann A, Weichert W, Kubicka S. Vogel A, et al. Among authors: siveke jt. Eur J Cancer. 2018 Mar;92:11-19. doi: 10.1016/j.ejca.2017.12.028. Epub 2018 Feb 3. Eur J Cancer. 2018. PMID: 29413685 Clinical Trial.
A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.
Schug C, Gupta A, Urnauer S, Steiger K, Cheung PF, Neander C, Savvatakis K, Schmohl KA, Trajkovic-Arsic M, Schwenk N, Schwaiger M, Nelson PJ, Siveke JT, Spitzweg C. Schug C, et al. Among authors: siveke jt. Mol Cancer Res. 2019 Jan;17(1):310-320. doi: 10.1158/1541-7786.MCR-18-0185. Epub 2018 Sep 17. Mol Cancer Res. 2019. PMID: 30224540
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer.
Metzenmacher M, Váraljai R, Hegedüs B, Cima I, Forster J, Schramm A, Scheffler B, Horn PA, Klein CA, Szarvas T, Reis H, Bielefeld N, Roesch A, Aigner C, Kunzmann V, Wiesweg M, Siveke JT, Schuler M, Lueong SS. Metzenmacher M, et al. Among authors: siveke jt. Cancers (Basel). 2020 Feb 4;12(2):353. doi: 10.3390/cancers12020353. Cancers (Basel). 2020. PMID: 32033141 Free PMC article.
Mir34a constrains pancreatic carcinogenesis.
Hidalgo-Sastre A, Lubeseder-Martellato C, Engleitner T, Steiger K, Zhong S, Desztics J, Öllinger R, Rad R, Schmid RM, Hermeking H, Siveke JT, von Figura G. Hidalgo-Sastre A, et al. Among authors: siveke jt. Sci Rep. 2020 Jun 15;10(1):9654. doi: 10.1038/s41598-020-66561-1. Sci Rep. 2020. PMID: 32541781 Free PMC article.
232 results